← back to search

Luc Dupuis

University of Fribourg ·
Area of research
Neurology · Genetics
Research interest
Research interests include Amyotrophic lateral sclerosis, Biology, Medicine, Neurodegeneration, Neuroscience, and Internal medicine.
h-index
citations
1,635
works
21
NIH funding
primary concept
email

Recent publications

In‐depth analysis of data from the RAS‐ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis
European Journal of Neurology 2024cited by 8position: middledoi
Skeletal muscle in amyotrophic lateral sclerosis
Brain 2023cited by 88position: lastdoi
Integrative genetic analysis illuminates ALS heritability and identifies risk genes
Nature Communications 2023cited by 43position: lastdoi
Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis
Acta Neuropathologica 2023cited by 39position: lastdoi
Integrative genetic analyses illuminates ALS heritability and identifies novel risk genes
Zenodo (CERN European Organization for Nuclear Research) 2022cited by 0position: lastdoi
Integrative genetic analyses illuminates ALS heritability and identifies novel risk genes
Zenodo (CERN European Organization for Nuclear Research) 2022cited by 0position: lastdoi
Integrative genetic analyses illuminates ALS heritability and identifies novel risk genes
Zenodo (CERN European Organization for Nuclear Research) 2022cited by 0position: lastdoi
Hypothalamus and weight loss in amyotrophic lateral sclerosis
Handbook of clinical neurology 2021cited by 17position: lastdoi
Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis
Journal of Neurology Neurosurgery & Psychiatry 2020cited by 46position: middledoi
Effect of High‐Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis
Annals of Neurology 2019cited by 162position: middledoi
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial
The Lancet Neurology 2018cited by 80position: middledoi
Hypertonic Stress Causes Cytoplasmic Translocation of Neuronal, but Not Astrocytic, FUS due to Impaired Transportin Function
Cell Reports 2018cited by 61position: middledoi
Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis
Acta Neuropathologica 2017cited by 135position: lastdoi
Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?© Caroline Moreau <i>et al</i> . 2018; Published by Mary Ann Liebert, Inc. This Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Antioxidants and Redox Signaling 2017cited by 106position: middledoi
Toxic gain of function from mutant <scp>FUS</scp> protein is crucial to trigger cell autonomous motor neuron loss
The EMBO Journal 2016cited by 242position: lastdoi
Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis
Brain 2016cited by 101position: lastdoi
Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis
Acta Neuropathologica 2016cited by 47position: lastdoi
Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study
Journal of Neurology 2015cited by 98position: middledoi
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2013cited by 163position: middledoi
VAPB/ALS8 MSP Ligands Regulate Striated Muscle Energy Metabolism Critical for Adult Survival in Caenorhabditis elegans
PLoS Genetics 2013cited by 50position: middledoi
A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
PLoS ONE 2012cited by 149position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Albert C. Ludolph · German Center for Neurodegenerative Diseases12 papers (2012–2024) · 6 papers (2016–2024)Thomas Meyer · University Medical Center Freiburg6 papers (2012–2024) · 6 papers (2012–2024) · 6 papers (2013–2023)Jens Dreyhaupt · Medizinische Hochschule Hannover5 papers (2012–2024) · 5 papers (2012–2024) · 5 papers (2016–2023)Julian Großkreutz · KU Leuven5 papers (2012–2024)Jan Kassubek · Sunnybrook Health Science Centre5 papers (2012–2024) · 5 papers (2013–2017)Jochen H. Weishaupt · University of Mannheim4 papers (2016–2024)Andrea Sylvia Winkler · Technical University of Munich4 papers (2012–2024)Johannes Dorst · Johannes Gutenberg University Mainz4 papers (2015–2024)Susanne Petri · SMART Reading4 papers (2015–2024)Bertold Schrank · SMART Reading4 papers (2012–2020) · 3 papers (2016–2016) · 3 papers (2019–2023)Matthias Boentert · Ludwig-Maximilians-Universität München3 papers (2019–2024)Johannes Prudlo · Johannes Gutenberg University Mainz3 papers (2019–2024)